Blood pressure lowering for primary and secondary prevention of stroke.
Zhang
Haifeng
H
Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, Herestraat 49, Box 702, B-3000 Leuven, Belgium.
Thijs
Lutgarde
L
Staessen
Jan A
JA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D012307:Risk Factors; D055502:Secondary Prevention; D020521:Stroke / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents